# Sildenafil in Sever Intrauterine Growth Retardation

> **NCT03153215** · NA · COMPLETED · sponsor: **Beni-Suef University** · enrollment: 46 (actual)

## Conditions studied

- Intra-Uterine Growth Retardation

## Interventions

- **OTHER:** treatment
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03153215
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-06
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03153215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03153215, "Sildenafil in Sever Intrauterine Growth Retardation". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03153215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
